Clinical Trial Update: Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

View source ↗

Summary

A clinical trial update highlights concerns about cardiotoxicity in metastatic HER2-positive breast cancer patients treated with trastuzumab, pertuzumab, and ta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Cardiotoxicity., Anti Her2 Therapy. | Status: UNKNOWN